Seaport Therapeutics is a Biotech company based in Boston, Massachusetts. It has raised $330M in total funding. Latest round: Series A.
Seaport Therapeutics is a Biotech company based in Boston, Massachusetts. Seaport Therapeutics has raised $330M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2024. The round record for Seaport Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health. 4 distinct backers are named across the disclosed rounds.
Totals shown for Seaport Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026